Skip to main content
Elsevier

Journals in Microbiology and virology

Elsevier's Microbiology & Virology collection provides comprehensive coverage of viruses and microorganisms, addressing their impact on human, animal, and plant health. It includes topics such as prevention, treatment, and research of viral diseases like coronaviruses, flaviviruses, and viral hemorrhagic fevers. The collection delves into fields like Bacteriology, Mycology, and Microbial genetics, focusing on their roles in environmental, agricultural, and health-related contexts. This resource serves as a vital tool for scientists, facilitating the study of viruses and microorganisms and enabling the development of effective strategies for infectious disease prevention, diagnosis, and control.

  • Virology

    • ISSN: 0042-6822
    An Affiliated Journal of the World Society for Virology Launched in 1955, Virology is a broad and inclusive journal that welcomes submissions on all aspects of virology including plant, animal, microbial and human viruses. The journal publishes basic research as well as pre-clinical and clinical studies of vaccines, anti-viral drugs and their development, anti-viral therapies, and computational studies of virus infections. Any submission that is of broad interest to the community of virologists/vaccinol... and reporting scientifically accurate and valuable research will be considered for publication, including negative findings and multidisciplinary work. Virology is open to reviews, research manuscripts, short communication, registered reports as well as follow-up manuscripts.For more information on article types, please visit our guide for authors: https://www.elsevier... Virology offers guaranteed peer review of Follow-Up as well as Research Articles, provided the Corresponding Author is the same and the new manuscript is submitted within 24 months of the previous paper getting accepted.
    Subscriptions

  • Immunology Letters

    • ISSN: 0165-2478
    Published by Elsevier as the official journal of the European Federation of Immunological Societies (EFIS), a member of the International Union of Immunological SocietiesImmunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular, cellular, and clinical immunology. As the official journal of the European Federation of Immunological Societies (EFIS), Immunology Letters supports international consortia of experts. The journal welcomes collaborative contributions dedicated to the state-of-the-art of immunology topics, as well as commentaries on those topics.Preference is given to papers of immediate importance to other investigators. Therefore, the essential criteria for publication are clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas are considered for publication provided they are based on solid experimental findings. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.
    Subscriptions

  • Nanomedicine: Nanotechnology, Biology and Medicine

    • ISSN: 1549-9634
    Nanomedicine: Nanotechnology, Biology and Medicine (NBM) is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.Nanomedicin... Nanotechnology, Biology, and Medicine aims to promote the interdisciplinary field of nanomedicine.The journal publishes topics including:artificial cellsregenerative medicinegene therapyinfectious diseasenanotechnolog... celltissue engineeringSub-categ... include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; public health; toxicology; theranostics; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.
    Subscriptions

  • The Lancet Infectious Diseases

    • ISSN: 1473-3099
    The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide.As the global leader in clinical infectious diseases, The Lancet Infectious Diseases delivers essential original research, expert review, candid commentary, and breaking news to provide context and perspective on today's most important medical advances across the broad spectrum of clinical infectious diseases.
    Subscriptions

Related subjects